Home / Data / Women's Health Trial Tracker Women's Health Trial Tracker Women's Health Trial Tracker organizes records from ClinicalTrials.gov API v2 into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 5,000
Last changed 08/26/2026
Update schedule 55 1 * * * UTC
Coverage 05/26/2000–08/25/2026 Record Record Date Vuga Group Change Status Recency Days Public Significance Score Cost-Effectiveness of an mHealth Application in Pregnancy Care 06/02/2026 INTERVENTIONAL unchanged 85.85 14.148 Evaluating the De-Escalation of Surveillance for Patients Who Have Undergone Curative Treatment for Primary Breast Cancer 06/01/2026 INTERVENTIONAL unchanged 86.85 13.148 Rectosigmoid Lesion Excision vs. Resection: A Non-Inferiority Randomized Comparison in Advanced Ovarian Cancer 06/01/2026 INTERVENTIONAL unchanged 86.85 13.148 Prediction of Platelet Function Using Viscoelastic Test (ROTEM® Sigma) in Obstetric Anesthesia. 06/01/2026 OBSERVATIONAL unchanged 86.85 13.148 MicroRNA and Markers and Therapeutic Response to Romosozumab and Abaloparatide in Postmenopausal Osteoporosis 06/01/2026 INTERVENTIONAL unchanged 86.85 13.148 Fovinaciclib Plus Aromatase Inhibitors and Dual HER2 Blockade in a Response-Adapted Neoadjuvant Strategy for HR-Positive/HER2-Positive Early Breast Cancer 06/01/2026 INTERVENTIONAL unchanged 86.85 13.148 Pilot Study on the Clinical Efficacy of Focused Ultrasound-Mediated Targeted Drug Delivery System Combined With Neoadjuvant Therapy for HER2-Positive Breast Cancer 06/01/2026 INTERVENTIONAL unchanged 86.85 13.148 Efficacy and Safety of Culmerciclib Plus Aromatase Inhibitors in a Response-Adapted Neoadjuvant Strategy for Highly Proliferative ER-Positive/HER2-Negative Breast Cancer 06/01/2026 INTERVENTIONAL unchanged 86.85 13.148 Letrozole vs. Clomiphene Citrate Plus Tamoxifen for Ovulation Induction and Pregnancy Outcomes. 06/01/2026 INTERVENTIONAL unchanged 86.85 13.148 Effects of Estrogen on Muscle Gain During 12-weeks of Exercise in Post-menopausal Women 06/01/2026 INTERVENTIONAL unchanged 86.85 13.148 Dual-Targeting CAR-NK Cells for Recurrent Ovarian Cancer (MSLN, FRα, MUC16) pt2 06/01/2026 INTERVENTIONAL unchanged 86.85 13.148 Study on the Functional Impact of Cosmetics on Improving Self-Esteem and Quality of Life in Black Women 06/01/2026 INTERVENTIONAL unchanged 86.85 13.148 Graded Motor Imagery for Primary Dysmenorrhea 06/01/2026 INTERVENTIONAL unchanged 86.85 13.148 Postpartum Exercise Intervention 05/29/2026 INTERVENTIONAL unchanged 89.85 10.148 The Efficacy and Safety of Inpegsomatropin Injection in Children With Turner Syndrome (TS) and Short Stature 05/29/2026 INTERVENTIONAL unchanged 89.85 10.148 Silodosin for Urinary Symptoms in Female Patients With Multiple Sclerosis 05/29/2026 INTERVENTIONAL unchanged 89.85 10.148 AGEWISE: Unravelling the Gut-Hormone Axis in Women's Ageing 05/29/2026 OBSERVATIONAL unchanged 89.85 10.148 Effect of Reflexology on Pain and Sleep Disorders in Females With Fibromyalgia 05/29/2026 INTERVENTIONAL unchanged 89.85 10.148 Pyrotinib and Trastuzumab Combined With Dalpiciclib Versus Combined With Docetaxel in Advanced HER2-Positive Breast Cancer 05/29/2026 INTERVENTIONAL unchanged 89.85 10.148 Nutritional Supplementation on Physiological and Metabolic Markers in Females 05/29/2026 INTERVENTIONAL unchanged 89.85 10.148 Structured Combined Exercise Program in Postmenopausal Women: Effects on Heart Rate Variability and Menopausal Symptoms 05/29/2026 INTERVENTIONAL unchanged 89.85 10.148 Health Benefits of Dance Exercise 05/29/2026 INTERVENTIONAL unchanged 89.85 10.148 Efficacy of a GLP-1/FGF21 Dual Agonist for Treating PCOS 05/29/2026 INTERVENTIONAL unchanged 89.85 10.148 Clinical Value of Saline Infusion Sonohysterography in the Assessment of Cesarean Scar Defects 05/28/2026 OBSERVATIONAL unchanged 90.85 9.148 Dalpiciclib, Anti-HER2 Therapy, and Endocrine Therapy for Hormone-Receptor-Positive, HER2-Positive Metastatic Breast Cancer 05/28/2026 INTERVENTIONAL unchanged 90.85 9.148 Care4mommies in Action: A Compassion-based Intervention 05/28/2026 INTERVENTIONAL unchanged 90.85 9.148 To Evaluate the Safety and Effectiveness of Intrauterine Adhesion Preventer in the Prevention and Treatment of Intrauterine Adhesions, a Prospective, Multicenter, Randomized Controlled Clinical Trial 05/28/2026 INTERVENTIONAL unchanged 90.85 9.148 A Multicenter, Prospective, Randomized Controlled Clinical Study on the Effect of Hysteroscopic Uterine Septum Resection on IVF-ET Outcomes in Infertile Patients With Non-recurrent Miscarriage 05/28/2026 INTERVENTIONAL unchanged 90.85 9.148 Elacestrant in Advanced Triple Positive Breast Cancer 05/28/2026 INTERVENTIONAL unchanged 90.85 9.148 A Study to Measure Mirikizumab Levels in Breast Milk of Lactating Participants Receiving Mirikizumab Therapeutically for an Approved Indication 05/28/2026 INTERVENTIONAL unchanged 90.85 9.148 Performance of Diffusion-weighted Imaging-based Virtual MR Elastography (vMRE) for Diagnosing Breast Cancer 05/27/2026 INTERVENTIONAL unchanged 91.85 8.148 The Value of Time-Dependent Diffusion MRI and Magnetic Resonance Elastography in the Precise Diagnosis and Efficacy Assessment of Breast Cancer 05/27/2026 INTERVENTIONAL unchanged 91.85 8.148 The Treatment Outcomes of Cesarean Scar Pregnancy 05/27/2026 OBSERVATIONAL unchanged 91.85 8.148 Comparing Decidual Inclusion vs. Exclusion in Uterine Suture Techniques During Cesarean Section to Improve Scar Thickness and Reduce Isthmocele Risk in Primiparous Women 05/27/2026 INTERVENTIONAL unchanged 91.85 8.148 Mitigation of Health Effects in Pregnant Women by Reducing Exposure to Heat and Air Pollution 05/27/2026 INTERVENTIONAL unchanged 91.85 8.148 Feasibility and Implementation of Early Referral in Perinatal Mental Health 05/27/2026 INTERVENTIONAL unchanged 91.85 8.148 The Relationship Between Oxytocin Massage in Mothers With Insufficient Milk Production in the Early Postpartum Period and Breastfeeding Self-Efficacy and Milk Let-down Reflex: A Randomized Controlled Study 05/27/2026 INTERVENTIONAL unchanged 91.85 8.148 HOME EXERCISE AND KINESIO TAPING IN NON-SPECIFIC NECK PAIN AMONG CHAIN MARKET WORKERS 05/27/2026 INTERVENTIONAL unchanged 91.85 8.148 Hypofractionated Whole Pelvic Chemoradiotherapy With iRex Optimization in Cervical Cancer 05/26/2026 INTERVENTIONAL unchanged 92.85 7.148 Accuracy of Transabdominal Ultrasound in Predicting Intraperitoneal Adhesions Prior to Laparoscopy 05/26/2026 OBSERVATIONAL unchanged 92.85 7.148 Acupoint TENS vs Resistance Training for Iron Deficiency Anemia 05/26/2026 INTERVENTIONAL unchanged 92.85 7.148 Virtual Forest-Based Mindfulness for Perinatal Mental Health 05/26/2026 INTERVENTIONAL unchanged 92.85 7.148 Clinical Efficacy Study of Jinfeng Pill in the Treatment of Perimenopausal Syndrome 05/26/2026 INTERVENTIONAL unchanged 92.85 7.148 Combination of Superior Hypogastric Plexus Block and Transversus Abdominis Plane Block in Abdominal Hysterectomies 05/26/2026 INTERVENTIONAL unchanged 92.85 7.148 Utility of Whole Genome Sequencing in Fetuses With Abnormal Ultrasound Findings 05/26/2026 OBSERVATIONAL unchanged 92.85 7.148 Effects of Negative Pressure Wound Bandaging After Mastectomy 05/26/2026 INTERVENTIONAL unchanged 92.85 7.148 Large Algorithm Setting and Validation Study 05/26/2026 OBSERVATIONAL unchanged 92.85 7.148 Parents and Babies Pilot 05/26/2026 INTERVENTIONAL unchanged 92.85 7.148 Effect of Isometric Handgrip Exercise on Blood Pressure in Pregnant Women 05/26/2026 INTERVENTIONAL unchanged 92.85 7.148 Polarized Light Therapy for Radiation Dermatitis in Breast Cancer 05/22/2026 INTERVENTIONAL unchanged 96.85 3.148
Source U.S. National Library of Medicine, ClinicalTrials.gov API v2 · official record · retrieved 08/26/2026 · upstream last modified 08/26/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. National Library of Medicine
Required notice Study records are informational and do not provide diagnosis, treatment advice, or an assessment of individual risk. What we add We compute Vuga Group, Change Status, Recency Days, Public Significance Score using the documented compute method. · methodology